Provider review
MadeMed review
Tablets and injections for both molecules, priced flat, on three-month plans.
One figure at every dose removes titration surprises and charges a quarter dose like a full one.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated October 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
$239/mo flat
Visit MadeMedPrice as published
MadeMed
$239/mo flat
- Vs median
- $70/mo above the $169 median
- Market
- $59–$1,300/mo across 261 of 407
- Structure
- Same price at every dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Taking less costs the same here. MadeMed prices every product the same at every dose, and says plainly that it does so to keep money out of titration decisions. A reader holding at a quarter dose pays what a reader at the full dose pays. What it does well is give you a choice of route and a lot of control over the bill. Both molecules come as sublingual tablets as well as injections, and your dose changes only when you ask. It emails a week before every charge, cancels in one click, and stops billing the moment you pause. The cost of getting it wrong is the term. There is no monthly plan, so the smallest purchase is three months billed up front, and its tirzepatide sits among the dearest here. Injectable tirzepatide is sold in only 23 states, and it takes no insurance, HSA or FSA.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want a sublingual tablet of either molecule with a published price
- You expect to titrate upward and want no price change when you do
- You want warning before every charge and a one-click way out
Look elsewhere if
- You intend to stay at a small dose: flat pricing is the least economical structure for that
- You want to try one month before committing: the shortest plan is three
- You live outside its 23 tirzepatide states, or want to pay with HSA or FSA funds
What it actually costs
Price as published
$239/mo flat
- Vs median
- $70/mo above the $169 median across the 261 of 407 programs here that publish a plain monthly rate
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Same price at every dose
One figure regardless of how much drug you take. Reassuring if you expect to titrate upward, and the least economical structure on this page if you do not: a quarter dose costs what a full one does.
95 of the 407 programs here price a small dose this way. Publishes one price at every dose for injections and sublingual tablets of both molecules, so a quarter dose costs what a full dose does. The shortest plan is three months, billed up front.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Flat at every dose
What it does well
- Sublingual tablets of both molecules as well as injections
- One price published at every dose, with the reason stated, so nothing changes if you titrate up
- An email seven days before every charge, one-click cancellation, and a pause that stops billing at once
- Your dose changes only when you ask; free overnight shipping with supplies, and meal plans included
- LegitScript-certified, with physician review and a refund minus a visit fee if you are not prescribed
Pharmacy, labs and oversight
MadeMed does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
3 of 4 published openly
What MadeMed publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsOne price at every dose, so the bill is knowable before you titrate.
- Published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
MadeMed is a LegitScript-certified telehealth platform led by board-certified physicians, selling compounded semaglutide and tirzepatide as weekly injections and as daily sublingual tablets. Every product is priced the same at every dose, from 0.25 mg to 2.4 mg of injected semaglutide and 2.5 mg to 15 mg of tirzepatide, and it explains why: so a dose change is never a revenue decision. The shortest plan is three months, billed up front, with medication shipped every two months, and your dose changes only when you ask. A physician reviews your online visit without a video call; if you are not prescribed, you are refunded less a visit fee. It emails seven days before every charge, cancels in one click, and stops billing the moment you pause. Shipping is free and overnight, with supplies included, and meal plans and exercise programs come at no extra cost. It does not take insurance, HSA or FSA, does not name its compounding pharmacies, and sells injectable tirzepatide in 23 states.
The honest cons
Flat pricing means a low-dose patient pays the full-dose rate, the least economical structure for anyone staying small
- No monthly plan: the shortest commitment is three months, billed up front
- Among the dearest tirzepatide prices here
- Injectable tirzepatide is sold in only 23 states
- No insurance, HSA or FSA payment, and the compounding pharmacies are not named
- Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
MadeMed is one of 407 low-dose GLP-1 programs compared on this site, and 261 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Where this sits
#16 of 407
Ordered with the companies that pay us first, and MadeMed is one of them. A disclosed partition, not a score.
Compare all 407 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- Oral semaglutide (Rybelsus)
- Microdosing tirzepatide
- Titrating up from a microdose
- Microdose & reconstitution calculator
- Titration planner
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
SnagRx
$99/mo flat at every dose
- Vs median
- $70/mo below the $169 median
- Market
- $59–$1,300/mo across 261 of 407
- Structure
- Same price at every dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the SnagRx review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.